Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 12190370)

1.
2.

Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome.

Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, Lebel MH, Seidman E.

Pediatr Infect Dis J. 2000 Jul;19(7):642-7.

PMID:
10917223
3.

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.

Pediatrics. 2005 Jun;115(6):e673-80.

PMID:
15930195
4.

Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.

Proulx F, Toledano B, Phan V, Clermont MJ, Mariscalco MM, Seidman EG.

Pediatr Res. 2002 Dec;52(6):928-34.

PMID:
12438672
5.

Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.

Smith KE, Wilker PR, Reiter PL, Hedican EB, Bender JB, Hedberg CW.

Pediatr Infect Dis J. 2012 Jan;31(1):37-41. doi: 10.1097/INF.0b013e31823096a8.

PMID:
21892124
6.

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.

Tarr PI, Watkins SL, Neill MA.

JAMA. 2002 Dec 25;288(24):3111-2; author reply 3112. No abstract available.

PMID:
12495389
7.

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.

Wong CS, Brandt JR.

JAMA. 2002 Dec 25;288(24):3111; author reply 3112. No abstract available.

PMID:
12495388
8.

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.

Gill CJ, Hamer DH, Lau J.

JAMA. 2002 Dec 25;288(24):3110-1; author reply 3112. No abstract available.

PMID:
12495387
9.

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI.

Clin Infect Dis. 2012 Jul;55(1):33-41. doi: 10.1093/cid/cis299. Epub 2012 Mar 19.

10.

Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.

Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI.

Pediatrics. 1997 Jul;100(1):E12.

PMID:
9200386
11.

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI.

N Engl J Med. 2000 Jun 29;342(26):1930-6.

12.

Antimicrobial therapy in patients with Escherichia coli O157:H7 infection.

Mølbak K, Mead PS, Griffin PM.

JAMA. 2002 Aug 28;288(8):1014-6. No abstract available.

PMID:
12190374
14.

Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.

Masri C, Proulx F, Toledano B, Clermont MJ, Mariscalco MM, Seidman EG, Carcillo J.

Am J Kidney Dis. 2000 Oct;36(4):687-94.

PMID:
11007669
15.

[Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak].

Higami S, Nishimoto K, Kawamura T, Tsuruhara T, Isshiki G, Ookita A.

Kansenshogaku Zasshi. 1998 Mar;72(3):266-72. Japanese.

PMID:
9643979
16.

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.

Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L.

J Pediatr. 1992 Aug;121(2):299-303.

PMID:
1640303
17.

Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian inuit community: intestinal illness in family members as a risk factor.

Rowe PC, Orrbine E, Ogborn M, Wells GA, Winther W, Lior H, Manuel D, McLaine PN.

J Pediatr. 1994 Jan;124(1):21-6.

PMID:
8283372
18.

Is antibiotic therapy of mice and humans useful in Escherichia coli O157:H7 enteritis?

Proulx F, Seidman E.

Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):533-4. Review. No abstract available.

PMID:
10517188
19.

Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome.

Kawamura N, Yamazaki T, Tamai H.

Pediatr Int. 1999 Apr;41(2):218-22.

PMID:
10221033
20.

Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005.

Karpac CA, Lee A, Kunnel BS, Bamgbola OF, Vesely SK, George JN.

J Okla State Med Assoc. 2007 Nov;100(11):429-33.

PMID:
18183860
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk